Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 31101627

Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2019 Jul 25
First author
Zucca E

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Zucca E
      type
      Author
    2. name
      Rondeau S
      type
      Author
    3. name
      Vanazzi A
      type
      Author
    4. name
      Østenstad B
      type
      Author
    5. name
      Mey UJM
      type
      Author
    6. name
      Rauch D
      type
      Author
    7. name
      Wahlin BE
      type
      Author
    8. name
      Hitz F
      type
      Author
    9. name
      Hernberg M
      type
      Author
    10. name
      Johansson AS
      type
      Author
    11. name
      de Nully Brown P
      type
      Author
    12. name
      Hagberg H
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Zucca E
      type
      Author
    2. name
      Rondeau S
      type
      Author
    3. name
      Vanazzi A
      type
      Author
    4. name
      Østenstad B
      type
      Author
    5. name
      Mey UJM
      type
      Author
    6. name
      Rauch D
      type
      Author
    7. name
      Wahlin BE
      type
      Author
    8. name
      Hitz F
      type
      Author
    9. name
      Hernberg M
      type
      Author
    10. name
      Johansson AS
      type
      Author
    11. name
      de Nully Brown P
      type
      Author
    12. name
      Hagberg H
      type
      Author
    bibliography ids
    1. nci-bib-d1d9f135f1ec33128916d3c8
    book metadata
    content sha256
    e8e2e87fe16888bc42b64c94ad155ee07f0f2a94e52943cfb85194101c28985c
    document type
    citation
    dois
    1. 10.1182/blood-2018-10-879643
    electronic publication date
    display
    2019 May 17
    precision
    day
    year
    2019
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:31101627
    immutable id
    pubmed:31101627@e8e2e87fe16888bc42b64c94ad155ee07f0f2a94e52943cfb85194101c28985c
    journal
    abbreviation
    Blood
    issn electronic
    1528-0020
    issn print
    0006-4971
    issue
    4
    name
    Blood
    nlm unique id
    7603509
    pages
    353-362
    volume
    134
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      31101627
      provenance
      batch id
      e808962322f3afebc564
      provider
      NCBI PubMed ESummary
      record sha256
      a4f8dbaee042d89863447643bc28f7919841702738986fc3704ed0293b4838ed
      response sha256
      3d610336ca8dae92b82cdb6b3ee6cab382eb509e0349b0c68c261b042b036561
      retrieved at
      2026-09-09T23:47:41.002093+00:00
      publication date
      display
      2019 Jul 25
      precision
      day
      year
      2019
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Multicenter Study
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/31101627/
      title
      Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy.

      Preserved source evidence · Independent clinical review pending · Not medical advice